Suppr超能文献

小鼠药代动力学研究。

Murine Pharmacokinetic Studies.

作者信息

Leblanc Alix F, Huang Kevin M, Uddin Muhammad Erfan, Anderson Jason T, Chen Mingqing, Hu Shuiying

机构信息

Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH, USA.

出版信息

Bio Protoc. 2018 Oct 20;8(20). doi: 10.21769/BioProtoc.3056.

Abstract

Murine pharmacokinetics (PK) represents the absorption, distribution, metabolism, and elimination of drugs from the body, which helps to guide clinical studies, ultimately resulting in more effective drug treatment. The purpose of this protocol is to describe a serial bleeding protocol, obtaining blood samples at six time points from single mouse to yield a complete PK profile. This protocol has proved to be rapid, highly repeatable, and relatively easy to acquire. Comparing with the conventional PK studies, this method not only dramatically reduces animal usage, but also decreases sample variation obtained from different animals.

摘要

小鼠药代动力学(PK)代表药物在体内的吸收、分布、代谢和排泄,这有助于指导临床研究,最终实现更有效的药物治疗。本方案的目的是描述一种连续采血方案,从单只小鼠的六个时间点采集血样,以获得完整的药代动力学曲线。该方案已被证明是快速、高度可重复且相对容易实施的。与传统的药代动力学研究相比,该方法不仅显著减少了动物的使用量,还降低了不同动物样本的变异性。

相似文献

1
Murine Pharmacokinetic Studies.
Bio Protoc. 2018 Oct 20;8(20). doi: 10.21769/BioProtoc.3056.
4
Capillary microsampling in mice: effective way to move from sparse sampling to serial sampling in pharmacokinetics profiling.
Xenobiotica. 2020 Jun;50(6):663-669. doi: 10.1080/00498254.2019.1683259. Epub 2019 Oct 30.
5
Fast mouse PK (Fast PK): a rapid screening method to increase pharmacokinetic throughput in pre-clinical drug discovery.
Eur J Pharm Sci. 2012 Sep 29;47(2):444-50. doi: 10.1016/j.ejps.2012.07.001. Epub 2012 Jul 9.
6
Utility of capillary microsampling for rat pharmacokinetic studies: Comparison of tail-vein bleed to jugular vein cannula sampling.
J Pharmacol Toxicol Methods. 2015 Nov-Dec;76:7-14. doi: 10.1016/j.vascn.2015.07.001. Epub 2015 Jul 9.
7
Impact of blood sampling technique on blood quality and animal welfare in haemophilic mice.
Lab Anim. 2011 Apr;45(2):114-20. doi: 10.1258/la.2010.010129. Epub 2011 Mar 7.
8
Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Curr Drug Metab. 2006 Feb;7(2):165-82. doi: 10.2174/138920006775541552.

引用本文的文献

1
Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice.
Molecules. 2025 Mar 24;30(7):1440. doi: 10.3390/molecules30071440.
2
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility.
Cancer Res Commun. 2025 Mar 1;5(3):496-510. doi: 10.1158/2767-9764.CRC-24-0475.
3
Based on UPLC-Q-TOF/MS and Network Pharmacology to Explore the Mechanism of Qingre Lishi Decoction in the Treatment of Psoriasis.
Drug Des Devel Ther. 2024 Aug 28;18:3871-3889. doi: 10.2147/DDDT.S467066. eCollection 2024.
4
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen.
Cancer Res Commun. 2024 Sep 1;4(9):2489-2497. doi: 10.1158/2767-9764.CRC-24-0332.
5
Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive UHPLC-MS/MS method for murine plasma analysis.
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Jul 15;1242:124209. doi: 10.1016/j.jchromb.2024.124209. Epub 2024 Jun 14.
6
Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice.
Drug Metab Dispos. 2024 Jan 9;52(2):80-85. doi: 10.1124/dmd.123.001466.
7
Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS method.
Heliyon. 2023 Oct 13;9(11):e20972. doi: 10.1016/j.heliyon.2023.e20972. eCollection 2023 Nov.
8
Determination and disposition of meta-iodobenzylguanidine in plasma and heart of transporter-deficient mice by UPLC-MS/MS.
J Chromatogr B Analyt Technol Biomed Life Sci. 2023 May 1;1222:123699. doi: 10.1016/j.jchromb.2023.123699. Epub 2023 Apr 7.
9
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.
Cancer Res Commun. 2022 Nov;2(11):1334-1343. doi: 10.1158/2767-9764.crc-22-0172. Epub 2022 Nov 3.
10
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B.
Molecules. 2022 Oct 12;27(20):6815. doi: 10.3390/molecules27206815.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验